China NMPA approves Harbour BioMed’s BLA for batoclimab injection to treat generalized myasthenia gravis: Cambridge, Massachusetts Saturday, October 24, 2026, 17:00 Hrs [IST] Ha ...
HanAll Biopharma's batoclimab has secured its first regulatory approval, with China authorizing the antibody treatment for ...
Whole-cell recordings and viral retrograde tracing in rats show that the interstitial nucleus of Cajal responds to ...
HanAll Biopharma wins China approval for myasthenia gravis drug batoclimab China grants NMPA nod to batoclimab for gMG after ...
सांप के न्यूरोटोक्सीन, निकोटिनिक एसिटाइलकोलाइन रिसेप्टर्स से जुड़कर नस और मांसपेशी के बीच के संपर्क को रोक सकते हैं. नेवलों ...
Laboratory electrophysiology, molecular simulations and mutational analysis identify an intersubunit transmembrane site ...
Clinically approved drugs induced ChAT expression and acetylcholine production in podocytes in vivo, suggesting the pathway could be pharmacologically targeted.
FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a ...
One-year results from the open-label extension of the phase III MINT trial presented at the American Association of ...
Why is nicotine so addictive? Learn how fast nicotine delivery, brain reward, cravings, withdrawal, smoking cues and ...
Atropine and PAM for organophosphate poisoning.” Even if you remember the combination, do you ever get confused when asked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results